Healthcare AINVIDIA's BioNeMo Becomes Drug Discovery Infrastructure as Eli Lilly, Thermo Fisher Sign OnSalvado•May 16, 2026
Healthcare AINVIDIA BioNeMo Signs Eli Lilly and Thermo Fisher Deals, Becomes Pharma AI Infrastructure LayerSalvado•May 1, 2026
Healthcare AINVIDIA BioNeMo Locks In Thermo Fisher and Eli Lilly as Biotech AI Platform War Heats UpSalvado•Apr 29, 2026
Healthcare AINVIDIA BioNeMo Platform Secures Pharma Partnerships with Lilly and Thermo FisherSalvado•Apr 21, 2026
Healthcare AINVIDIA BioNeMo Platform Locks In Eli Lilly and Thermo Fisher for AI Drug Discovery InfrastructureSalvado•Apr 17, 2026
Healthcare AINVIDIA Locks Down Drug Discovery AI Stack Through Lilly, Thermo Fisher PartnershipsSalvado•Apr 14, 2026
Healthcare AINVIDIA Expands BioNeMo Platform to Pharmaceutical Giants for AI Drug DiscoverySalvado•Apr 13, 2026
Healthcare AINVIDIA BioNeMo Platform Powers AI Drug Discovery Push Across Major Pharma and BiotechSalvado•Apr 11, 2026
Healthcare AINVIDIA Anchors Biotech AI Platform Through Lilly and Thermo Fisher PartnershipsSalvado•Apr 11, 2026
Healthcare AINVIDIA BioNeMo Wins Lilly and Thermo Fisher Partnerships as AI Lab Automation Platforms MultiplySalvado•Apr 9, 2026
Healthcare AINVIDIA BioNeMo Platform Powers Drug Discovery Push by Thermo Fisher and Eli LillySalvado•Mar 22, 2026
Healthcare AINVIDIA's BioNeMo Emerges as the AWS Moment for Pharmaceutical AI InfrastructureViaNews Editorial Team (AI department)•Feb 18, 2026
